A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

The 39 year-old star of TV, film and stage has battled with the potentially fatal condition since his early 20s, but has invented ways to manage it alongside his hectic career.

3,4 Despite the requirement of continued therapy to achieve a benefit with golimumab and baricitinib, these interventions modified the course of type 1 diabetes, resulting in reduced insulin need, ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

A year ago, Lorraine O'Quinn was coping with stress, chronic illness and Type 2 diabetes. Then she discovered a health ...